Your browser doesn't support javascript.
loading
Priorities and Progress in Diagnostic Research by the Antibacterial Resistance Leadership Group.
Hanson, Kimberly E; Banerjee, Ritu; Doernberg, Sarah B; Evans, Scott R; Komarow, Lauren; Satlin, Michael J; Schwager, Nyssa; Simner, Patricia J; Tillekeratne, L Gayani; Patel, Robin.
Afiliación
  • Hanson KE; Division of Infectious Diseases, Department of Medicine, University of Utah, Salt Lake City, Utah, USA.
  • Banerjee R; Division of Clinical Microbiology, Department of Pathology, University of Utah, Salt Lake City, Utah, USA.
  • Doernberg SB; Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Evans SR; Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
  • Komarow L; Department of Biostatistics, George Washington University, Washington, DC, USA.
  • Satlin MJ; George Washington University Biostatistics Center, Rockville, Maryland, USA.
  • Schwager N; Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
  • Simner PJ; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.
  • Tillekeratne LG; Division of Medical Microbiology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Patel R; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Clin Infect Dis ; 77(Suppl 4): S314-S320, 2023 10 16.
Article en En | MEDLINE | ID: mdl-37843119
The advancement of infectious disease diagnostics, along with studies devoted to infections caused by gram-negative and gram-positive bacteria, is a top scientific priority of the Antibacterial Resistance Leadership Group (ARLG). Diagnostic tests for infectious diseases are rapidly evolving and improving. However, the availability of rapid tests designed to determine antibacterial resistance or susceptibility directly in clinical specimens remains limited, especially for gram-negative organisms. Additionally, the clinical impact of many new tests, including an understanding of how best to use them to inform optimal antibiotic prescribing, remains to be defined. This review summarizes the recent work of the ARLG toward addressing these unmet needs in the diagnostics field and describes future directions for clinical research aimed at curbing the threat of antibiotic-resistant bacterial infections.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por Bacterias Gramnegativas / Liderazgo Límite: Humans Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por Bacterias Gramnegativas / Liderazgo Límite: Humans Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos